FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) Stock Analyst Earnings Estimates
NASDAQ:FBIOP - Nasdaq - US34960Q2084 - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 75.74M 10.10% | 84.513M 11.58% | 57.675M -31.76% | 87.427M 51.59% | 126.54M 44.74% | 202.78M 60.25% | 680.14M 235.41% | 721.75M 6.12% | 736.44M 2.04% | |
| EBITDA YoY % growth | -196.17M -12.81% | -133.245M 32.08% | -106.776M 19.86% | -42.84M 59.88% | -34.374M 19.76% | -16.116M 53.12% | N/A | N/A | N/A | |
| EBIT YoY % growth | -203.56M -13.72% | -139.242M 31.60% | -111.24M 20.11% | -64.007M 42.46% | -35.034M 45.26% | -16.116M 54.00% | 180.74M 1,221.49% | 195.84M 8.35% | 188.5M -3.75% | |
| Operating Margin | -268.76% | -164.76% | -192.87% | -73.21% | -27.69% | -7.95% | 26.57% | 27.13% | 25.60% | |
| EPS YoY % growth | -14.51 -132.54% | -8.97 38.18% | -3.27 63.55% | -1.43 56.33% | -0.84 41.07% | -0.47 44.24% | N/A | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.37 49.70% | -0.31 59.74% | -0.25 66.68% |
| Revenue Q2Q % growth | 14.825M -0.48% | 19.671M 34.47% | 39.53M 161.44% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.681M 25.69% | -14.361M 35.01% | -8.201M 70.01% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.48 53.40% | -0.50 | 0.02 | 4.93% |
| Q4 2024 Q2Q % growth | -0.75 41.41% | -0.77 | 0.02 | 2.39% |
| Q3 2024 Q2Q % growth | -0.76 19.15% | -0.61 | -0.15 | -25.23% |
| Q2 2024 Q2Q % growth | -0.73 79.72% | -1.25 | 0.52 | 41.50% |
| Q1 2024 Q2Q % growth | -1.03 67.30% | -1.76 | 0.73 | 41.63% |
| Q4 2023 Q2Q % growth | -1.28 71.30% | -2.01 | 0.73 | 36.19% |
| Q3 2023 Q2Q % growth | -0.94 74.93% | -3.27 | 2.33 | 71.25% |
| Q2 2023 Q2Q % growth | -3.60 | -3.48 | -0.12 | -3.43% |
| Q1 2023 Q2Q % growth | -3.15 -16.67% | -3.06 | -0.09 | -2.94% |
| Q4 2022 Q2Q % growth | -4.46 21.74% | -3.44 | -1.02 | -29.57% |
| Q3 2022 Q2Q % growth | -3.75 -2,578.57% | -4.13 | 0.38 | 9.22% |
| Q2 2022 Q2Q % growth | -3.60 -1,141.38% | -3.21 | -0.39 | -12.04% |
| Q1 2022 Q2Q % growth | -2.70 -2,354.55% | -4.28 | 1.58 | 36.97% |
| Q4 2021 Q2Q % growth | -5.70 -11,300.00% | 2.69 | -8.39 | -311.68% |
| Q3 2021 Q2Q % growth | -0.14 30.00% | -0.08 | -0.06 | -68.06% |
| Q2 2021 Q2Q % growth | -0.29 -52.63% | -0.13 | -0.16 | -127.45% |
| Q1 2021 Q2Q % growth | -0.11 42.11% | -0.11 | 0.00 | 0.15% |
| Q4 2020 Q2Q % growth | -0.05 81.48% | -0.14 | 0.09 | 64.99% |
| Q3 2020 Q2Q % growth | -0.20 9.09% | -0.22 | 0.02 | 10.19% |
| Q2 2020 Q2Q % growth | -0.19 20.83% | -0.27 | 0.08 | 29.97% |
| Q1 2020 Q2Q % growth | -0.19 29.63% | -0.23 | 0.04 | 19.01% |
| Q4 2019 Q2Q % growth | -0.27 | -0.31 | 0.04 | 14.06% |
| Q3 2019 Q2Q % growth | -0.22 | -0.31 | 0.09 | 28.10% |
| Q2 2019 Q2Q % growth | -0.24 | -0.47 | 0.23 | 48.85% |
| Q1 2019 Q2Q % growth | -0.27 | -0.59 | 0.32 | 54.36% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 13.139M 0.84% | 11.853M | 1.286M | 10.85% |
| Q4 2024 Q2Q % growth | 15.12M -24.20% | 16.623M | -1.503M | -9.04% |
| Q3 2024 Q2Q % growth | 14.629M -57.90% | 32.862M | -18.233M | -55.48% |
| Q2 2024 Q2Q % growth | 14.896M -14.32% | 15.068M | -172K | -1.14% |
| Q1 2024 Q2Q % growth | 13.03M 4.84% | 14.413M | -1.383M | -9.60% |
| Q4 2023 Q2Q % growth | 19.946M 21.62% | 15.192M | 4.754M | 31.29% |
| Q3 2023 Q2Q % growth | 34.752M 110.24% | 14.869M | 19.883M | 133.72% |
| Q2 2023 Q2Q % growth | 17.386M -7.96% | 15.884M | 1.502M | 9.46% |
| Q1 2023 Q2Q % growth | 12.429M -48.06% | 17.762M | -5.333M | -30.02% |
| Q4 2022 Q2Q % growth | 16.4M -10.28% | 22.495M | -6.095M | -27.09% |
| Q3 2022 Q2Q % growth | 16.53M -21.62% | 21.248M | -4.718M | -22.20% |
| Q2 2022 Q2Q % growth | 18.89M 5.89% | 23.643M | -4.753M | -20.10% |
| Q1 2022 Q2Q % growth | 23.93M 106.47% | 21.087M | 2.843M | 13.48% |
| Q4 2021 Q2Q % growth | 18.28M 32.95% | 49.282M | -31.002M | -62.91% |
| Q3 2021 Q2Q % growth | 21.09M 122.47% | 18.792M | 2.298M | 12.23% |
| Q2 2021 Q2Q % growth | 17.84M 88.58% | 14.987M | 2.853M | 19.04% |
| Q1 2021 Q2Q % growth | 11.59M -10.29% | 13.681M | -2.091M | -15.28% |
| Q4 2020 Q2Q % growth | 13.75M 23.54% | 12.407M | 1.343M | 10.82% |
| Q3 2020 Q2Q % growth | 9.48M -2.97% | 11.548M | -2.068M | -17.91% |
| Q2 2020 Q2Q % growth | 9.46M 2.27% | 11.252M | -1.792M | -15.93% |
| Q1 2020 Q2Q % growth | 12.92M 99.38% | 11.521M | 1.399M | 12.14% |
| Q4 2019 Q2Q % growth | 11.13M | 11.695M | -565K | -4.83% |
| Q3 2019 Q2Q % growth | 9.77M | 8.398M | 1.372M | 16.34% |
| Q2 2019 Q2Q % growth | 9.25M | 7.656M | 1.594M | 20.82% |
| Q1 2019 Q2Q % growth | 6.48M | 6.538M | -58K | -0.89% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 19.1% | 0% | 12.86% |
| Revenue | 0% | -7.9% | 0% | -7.12% |